IgG Glycan Hydrolysis Attenuates ANCA-Mediated Glomerulonephritis
Open Access
- 1 July 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Society of Nephrology
- Vol. 21 (7), 1103-1114
- https://doi.org/10.1681/asn.2009090984
Abstract
Anti-neutrophil cytoplasmic autoantibodies (ANCA) directed against myeloperoxidase (MPO) and proteinase 3 (Pr3) are considered pathogenic in ANCA-associated necrotizing and crescentic glomerulonephritis (NCGN) and vasculitis. Modulation of ANCA IgG glycosylation may potentially reduce its pathogenicity by abolishing Fc receptor–mediated activation of leukocytes and complement. Here, we investigated whether IgG hydrolysis by the bacterial enzyme endoglycosidase S (EndoS) attenuates ANCA-mediated NCGN. In vitro, treatment of ANCA IgG with EndoS significantly attenuated ANCA-mediated neutrophil activation without affecting antigen-binding capacity. In a mouse model of anti-MPO IgG/LPS-induced NCGN, we induced disease with either unmodified or EndoS-treated (deglycosylated) anti-MPO IgG. In separate experiments, we administered EndoS systemically after disease induction with unmodified anti-MPO IgG. Pretreatment of anti-MPO IgG with EndoS reduced hematuria, leukocyturia, and albuminuria and attenuated both neutrophil influx and formation of glomerular crescents. After inducing disease with unmodified anti-MPO IgG, systemic treatment with EndoS reduced albuminuria and glomerular crescent formation when initiated after 3 but not 24 hours. In conclusion, IgG glycan hydrolysis by EndoS attenuates ANCA-induced neutrophil activation in vitro and prevents induction of anti-MPO IgG/LPS-mediated NCGN in vivo. Systemic treatment with EndoS early after disease induction attenuates the development of disease. Thus, modulation of IgG glycosylation is a promising strategy to interfere with ANCA-mediated inflammatory processes.This publication has 46 references indexed in Scilit:
- Experimental Autoimmune Vasculitis: An Animal Model of Anti-neutrophil Cytoplasmic Autoantibody-Associated Systemic VasculitisThe American Journal of Pathology, 2009
- Coexpression of CD177 and membrane proteinase 3 on neutrophils in antineutrophil cytoplasmic autoantibody–associated systemic vasculitis: Anti–proteinase 3–mediated neutrophil activation is independent of the role of CD177‐expressing neutrophilsArthritis & Rheumatism, 2009
- In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent mannerProceedings of the National Academy of Sciences of the United States of America, 2008
- Mechanisms of ANCA-Mediated Leukocyte-Endothelial Cell Interactions In VivoJournal of the American Society of Nephrology, 2008
- IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditionsProceedings of the National Academy of Sciences of the United States of America, 2008
- Human IgG/FcγR Interactions Are Modulated by Streptococcal IgG Glycan HydrolysisPLOS ONE, 2008
- Alternative Complement Pathway in the Pathogenesis of Disease Mediated by Anti-Neutrophil Cytoplasmic AutoantibodiesThe American Journal of Pathology, 2007
- Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitidesNature Clinical Practice Rheumatology, 2006
- Constitutive membrane expression of proteinase 3 (PR3) and neutrophil activation by anti-PR3 antibodiesJournal of Leukocyte Biology, 2004
- Predominance of IgGl and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disordersClinical and Experimental Immunology, 1991